1. Wendy Saviour Director of Commissioning Development
Safer, high quality care
Better patient experience
Improved health
Value for money
Real influence
More accessible services

2. Liberating for Excellence
Aims
To:
Empower clinicians to design services and make commissioning decisions in return for accountability for results.
Empower patients to exercise choice and local populations to improve quality.
Create a competitive market environment.

3. Commissioning for patients
How:
GP Commissioners
PCTs
NHS Commissioning Board
Local Authority

4. Managing the transition
SHA role:
Build on progress made in the East Midlands in respect of commissioning
Work and operate on the principle of subsidiarity
Consider collaborative commissioning arrangements, (primary care, specialised, prisons, maternity)
Advise, support and assure on the development of GP commissioning
Influence emerging policy and the bill
To ensure appropriate Leadership development for GP Commissioners

5. Managing the transition
SHA Role Cont’d:
Ensure engagement with wider stakeholders LAs, secondary care and related work programmes
Develop authorisation process for shadow consortia in preparation for April 2011
Agree regional / national approach to regional budget setting
Regional Information review - October
Sharing best practice through existing networks - National pathfinders and PPI pilots
Identifying commissioning capability and stimulating the market

6. GP Consortia Role – emerging themes
All practices to be part of a GP commissioning consortium
Duty to manage resources effectively as a provider
Duty to offer choice
Consortia to work with LA to undertake needs assessment
Buy the services to meet the need
Ensure expenditure does not exceed resources available

7. GP Consortia Role – emerging themes
Consortia to monitor performance of practices
Consortia to allocate the ‘Quality premium’ to its constituent practices
Consortia to have an Accountable Officer and Chief Financial Officer
Inform engage and involve the public
Manage contracts with providers

8. GP Consortia Authorisation – emerging themes
Consortium constitution
Financial controls
Geography – appropriate to address local issues
Population size – viability
Patient and public views
Capability – internal and bought

9. Key issues Funding and incentives unknown at this stage GP contract
Legacy financial positions
Flexibilities to provide ?
Clinical ownership to bring about behavioural change
Relationships and stakeholder engagement
FT universality
Integration v competition & choice

10. Early thoughts on regional work programme
What are the emerging issues for you?
What do you need to support the development of shadow consortia?
Roles and responsibilities - Doing the right things at the right level. Consortia, PCT and SHA. (principle of subsidiarity)